Search Login Register

Vocal Cord Paralysis Summary

Description: Congenital or acquired paralysis of one or both VOCAL CORDS. This condition is caused by defects in the CENTRAL NERVOUS SYSTEM, the VAGUS NERVE and branches of LARYNGEAL NERVES. Common symptoms are VOICE DISORDERS including HOARSENESS or APHONIA.

Also Known As: Acquired Vocal Cord Palsy; Bilateral Vocal Cord Paresis; Congenital Vocal Cord Palsy; Paralysis, Unilateral, Vocal Cord; Paralysis, Vocal Cord, Unilateral Show All >>

Networked: 697 relevant articles (27 outcomes, 45 trials/studies) for this Disease

Key Drugs and Agents for Vocal Cord Paralysis

Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
  1. Polytetrafluoroethylene (Teflon) : 2 outcomes 1 study in 48 results : FDA 1
  2. Carbon Monoxide : 1 outcome 1 study in 6 results : IBA
  3. Elastomers (Elastomer) : 1 outcome 1 study in 1 result : IBA
  4. Durapatite (Hydroxylapatite) : 1 outcome 1 study in 1 result : IBA
  5. polymethylsiloxane : 1 outcome 1 study in 1 result : IBA
  6. Bioplastique : 1 outcome 1 study in 1 result : IBA
  7. Botulinum Toxins (Botulinum Toxin) : 1 outcome in 5 results : IBA
  8. baysilon (polydimethylsiloxane) : 1 outcome in 4 results : IBA
  9. Titanium : 1 outcome in 2 results : IBA
  10. Adrenal Cortex Hormones (Corticosteroids) : 1 outcome in 2 results : IBA
Show All >>

Diseases Related to Vocal Cord Paralysis

  1. Airway Obstruction (Choking)
  2. Hypoparathyroidism
  3. Dysphonia (Spastic Dysphonia)
  4. Respiratory Sounds (Crackle)
  5. Aspiration Pneumonia
Show All >>

Key Therapies for Vocal Cord Paralysis

Efficacy Chart >>
  1. Laryngoplasty : 6 outcomes 9 studies in 78 results
  2. Thyroidectomy : 2 outcomes 7 studies in 96 results
  3. Lasers (Laser) : 2 outcomes 3 studies in 33 results
  4. Tracheostomy : 2 outcomes in 63 results
  5. Continuous Positive Airway Pressure : 2 outcomes in 5 results
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.